PCOR Privacy and Security Research Scenario Initiative and Legal Analysis and Ethics Framework Development Welcome and Please Sign In »Please sign into.

Slides:



Advertisements
Similar presentations
1 The HIPAA Privacy Rule and Research This presentation will probably involve audience discussion, which will create action items. Use PowerPoint to keep.
Advertisements

NCVHS: Privacy and Confidentiality Leslie P. Francis, Ph.D., J.D. Distinguished Professor of Law and Philosophy Alfred C. Emery Professor of Law University.
The Protection of Human Subjects in Research Piece Presenter: Roxana Killian.
Good Clinical Research Practice Guidelines For Informed Consent Presented by Catherine May Acting Research Practice Development Officer The Office of Research.
Protecting the Privacy of Family Members in Survey and Pedigree Research Jeffrey R. Botkin, MD, MPH University of Utah.
Health Insurance Portability Accountability Act of 1996 HIPAA for Researchers: IRB Related Issues HSC USC IRB.
Project Update : Claims/Clinical Linkage Project MHDO Board of Directors June 6, 2013.
Recently Issued OHRP Documents: Guidance on Subject Withdrawal and Draft Revised FWA Secretary’s Advisory Committee on Human Research Protections October.
1 HIPAA, Researchers and the IRB: Part Two Alan Homans, IRB Chair and Nancy Stalnaker, IRB Administrator.
CUMC IRB Investigator Meeting November 9, 2004 Research Use of Stored Data and Tissues.
Health Insurance Portability and Accountability Act (HIPAA)
2012 VA IRB Administrators Meeting Stephania H. Griffin, JD, RHIA, CIPP/G VHA Privacy Officer Director, Information Access and Privacy Privacy Officer.
1 VUMC Confidentiality Policy and HIPAA Implications for Clinical Research General Clinical Research Center Skills Workshop March 2, 2007 Gaye Smith Privacy.
Cornell Evaluation Network The Use of Human Participants in Research Office of Research Integrity and Assurance ~ May 14, 2007.
Human Research Protection Programs 1a: How to Navigate Human Subject Protection Regulations Sponsored by the American Society for Investigative Pathology.
1 Health Information Security and Privacy Collaboration (HISPC) National Conference HISPC Contributions to Massachusetts HIE Privacy and Security Progress:
Overview of Interoperability Standards Advisory Steve Posnack Director of Office of Standards and Technology, ONC 1.
Health Insurance Portability and Accountability Act (HIPAA)
Li Xiong CS573 Data Privacy and Security Healthcare privacy and security: Genomic data privacy.
Future Use of Stored Samples & Data and the NIH Policy on GWAS and dbGaP NIAID/DAIDS Dione Washington, M.S. -- ProPEP Sudha Srinivasan, Ph.D.-- TRP Tanisha.
“ Jericho / UT Austin Pilot” Privacy with Dynamic Patient Review April 9, 2013 Presented by: David Staggs, JD, CISSP Jericho Systems Corporation.
HIPAA and Research Basics for IRB Tim Atkinson Director, Research and Sponsored Programs Director, Institutional Review Board Research Privacy Officer.
HIPAA – How Will the Regulations Impact Research?.
Data Access Framework All Hands Community Meeting 1 September 23, 2015.
Module 3: Informed Consent. This training session contains information regarding: Documenting consent Documenting consent Conducting informed consent.
Privacy and Confidentiality. Definitions n Privacy - having control over the extent, timing, and circumstances of sharing oneself (physically, behaviorally,
Understanding HIPAA (Health Insurandce Portability and Accountability Act)
© 2013 The McGraw-Hill Companies, Inc. All rights reserved. Ch 8 Privacy Law and HIPAA.
Name Position Organisation Date. What is data integration? Dataset A Dataset B Integrated dataset Education data + EMPLOYMENT data = understanding education.
1 Ethical issues in genomics research Bernard Lo, M.D. March 3, 2009.
The Patient Choice Project Project Kickoff December 14 th, 2015.
New York State DOH Health Home Care Management Reporting Tool (HH-CMART) Support Calls – Session #3 March 6,
CROWNWeb FMQAI: The Florida ESRD Network. Introductions Oniel Delva, BA Communications Coordinator Renal RCT Team – Network 7 CROWNWeb.
PCOR Privacy and Security Research Scenario Initiative and Legal Analysis and Ethics Framework Development Welcome and Please Sign In »Please sign into.
PCOR Privacy and Security Research Scenario Initiative and Legal Analysis and Ethics Framework Development Welcome and Please Sign In »Please sign into.
The Patient Choice Project Use Case Working Session February 12 th, 2016.
The Patient Choice Project Use Case Working Session February 5 th, 2016.
The Patient Choice Project Use Case Working Session January 29 th, 2016.
PCOR Privacy and Security Research Scenario Initiative and Legal Analysis and Ethics Framework Development Welcome and Please Sign In »Please sign into.
PCOR Privacy and Security Research Scenario Initiative and Legal Analysis and Ethics Framework Development Welcome and Please Sign In »Please sign into.
Privacy and Security Considerations in Research and Clinical Trials February 28, 2013 Joanna K. Napp, J.D., M.P.H. Chief Privacy Officer and Compliance.
PCOR Privacy and Security Research Scenario Initiative and Legal Analysis and Ethics Framework Development Welcome and Please Sign In »Please sign into.
HIPAA and RESEARCH 5 th Thursday May 31, Page 2.
Slide 1 Standard Operating Procedures. Slide 2 Goal To review the standard operating procedures Creating the informed consent document Obtaining informed.
HIPAA and Transitions Protected Health Information PHI.
Certificates of Confidentiality:
Denise Chrysler, JD Director, Mid-States Region
Overview of Plain Language Summary
COCE Institutional Review Board Academic Spotlight
To the ETS – Accounts Setup and Preferences Online Training Course
MAINTAINING THE INVESTIGATOR’S SITE FILE
The HIPAA Privacy Rule: Implications for Medical Research
Charlotte Crist, BS, RN-BC, CCM, CPHQ
Reportable Events & Other IRB Updates February 2017
Chemotherapy Order Management System (COMS)
Data Protection & Freedom of Information- An Introduction
StudentTranscripts Service Overview
Anca Miron, PhD IRB Chair, UW Oshkosh Kelly Schill, BS, CIP
The HIPAA Privacy Rule and Research
How we use Your Health Records
Systemic Student Support (S3) Academy
MAINTAINING THE INVESTIGATOR’S STUDY FILE
Introduction to Health Privacy
To the ETS – Accounts Setup and Preferences Online Training Course
TGmb Teleconferences January 2010 through March 2010
Risk Adjustment User Group
TGmb Teleconferences January 2010 through March 2010
2019 Spring & Fall Timeline May 10, 2019
Office of Research Integrity and Protections
Validity, Specificity, and Reliability Of Informed Consent
Presentation transcript:

PCOR Privacy and Security Research Scenario Initiative and Legal Analysis and Ethics Framework Development Welcome and Please Sign In »Please sign into the WebEx using your name and affiliation and/or record your name on the conference line after the prompt. »If you are not signing on to the WebEx, signing on anonymously, or did not record your name on the conference line, please Donaldson- to let us know you are on the phone.Donaldson- Participation »Please keep your own line muted throughout. »If you have a question, please raise your hand via the web and we will call upon you. »If you are not signed in to the web conference, please state your full name before speaking on the phone. »You may also questions or comments to Katherine Donaldson. 1

Patient Centered Outcomes Research (PCOR) Privacy and Security Research Scenario Initiative and Legal Analysis and Ethics Framework Development Stakeholder Work Group Meeting #11 April 20, 2016 NORC at the University of Chicago The George Washington University

Meeting Agenda Welcome Working through Research Data Use Scenarios »Mosaic Effect Use Case Analysis »Overview »Walking through Use Cases –Use Case 1: Combine Data for PCOR –Use Case 4: Identification and Re-Identification of PCOR Data Scenarios Under Revision Wrap-Up and Next Steps 3

Research Data Use Scenarios Prashila Dullabh, Daniella Meeker 4

New Scenarios Mosaic Effect » k+from+the+Mosaic+Effecthttp://confluence.siframework.org/display/PSRSI/Reindentification+Ris k+from+the+Mosaic+Effect 5

Overview of the Use Case Analysis Prashila Dullabh, Daniella Meeker 6

Overview of Progress and Structure 7 As a group, we have developed 16 scenarios to-date. They have sorted into specific thematic areas based on the type of process being performed. »E.g., Accessing Sensitive Behavioral Health Data for PCOR and Research Use Scenarios Related to Cumulative Re-identification Risks The thematic areas further cluster under various use cases, which reflect the technical aspects of the scenarios. »E.g., Consent Management and Use of Sensitive Data There are 16 scenarios grouped under 9 thematic areas, which fall under 5 use cases.

Organization of Research Data Use Scenarios under Use Cases 8 Use CaseThematic AreaScenario Use Case 1: Combine Data for PCOR Combining Independently Managed Data for PCOR Combining Clinical and Claims Data Combining Clinical Data with Birth Records Secondary Analysis of Administrative Data on Substance Use Treatment CER Use Case 2: Consent Management Research and Age-Related ConsentConsiderations Related to Consent and Transitions from Minor to Adult Research Data Use Scenarios on Special Populations and Protection Status Research Involving HIV-Positive Prisoners Consenting Individuals with Impaired Decision-Making Capacity Use Case 3: Release and Use of Protected Health Data for PCOR Accessing Sensitive Behavioral Health Data for PCOR Combining Mental Health Data with Physical Health Data Precision Medicine Consented Disclosures That Affect The Privacy of Family Members Testing and Disclosure of Genomic Data to a Minor Use of genetic bio-markers data for research Individual and Population-Level Research Related to Sub-Populations Privacy Concerns for American Indian/Alaska Native Individuals and/or Populations Use Case 4: Identification and Re-Identification of PCOR Data Research Use Scenarios Related to Cumulative Re-identification Risks Mosaic Effect: Precision Medicine Outside of Genomic Data Variations in Linkage Mechanisms/Availability of Unique Identifiers Creating A Multi-Institutional Unique Identifier for Research Use Case 5: Patient- Generated Health Data Patient-Generated Health Data Creating A Registry That Includes Patient Reported Outcomes Conducting Research on Patient Reported Outcomes within A Registry Use of Sensor Data

Use Case Analysis: Combine Data for PCOR Prashila Dullabh, Ioana Singureanu, Daniella Meeker 9

Use Case 1: Combine Data for PCOR, Thematic Areas and Scenarios 10

Use Case 1: Combine Data for PCOR, Preconditions Diagram 11

Use Case 1: Combine Data for PCOR, Workflow Diagram 12

Use Case Analysis: Identification and Re-Identification of PCOR Data Prashila Dullabh, Ioana Singureanu, Daniella Meeker 13

Use Case 4: Identification and Re-Identification of PCOR Data, Thematic Areas and Scenarios 14

Use Case 4: Identification and Re-Identification of PCOR Data, Preconditions Diagram 15

Use Case 4a Identification and Re-Identification of PCOR Data, Workflow Diagram: Using Identifying Traits 16

Use Case 4b Identification and Re-Identification of PCOR Data, Workflow Diagram: Using Hash Value 17

Legal Clarifications on constraints for privacy-preserving record linkage De-Identified data are not subject to HIPAA. »De-Identification under Safe-Harbor standards do not have utility for record linkage »De-Identification under Expert Determination may enable record linkage If an expert determination is obtained for hash approach, record linkage using hashed identifiers does not require a waiver of authorization or a BAA. »Expert determination must be based on the re-identification risk of the combined data, not merely the transferred data from each site separately. »Any subsequent re-identification requires HIPAA Waiver or consent. 18

Scenarios Under Revision Prashila Dullabh and Ioana Singureanu 19

Scenarios Under Comment and Revision Unintended Compromise of Participants Family Members’ Privacy, Identification of Health Risk » Collecting Clinical and Genetic Information to Study Serious Diseases, Risks to Patients/Family Members/Minors » Use of Genetic Biomarkers Data for Research » in+Researchhttp://confluence.siframework.org/display/PSRSI/Use+of+Genetic+Biomarkers+ in+Research 20

Wrap-up and Next Steps Prashila Dullabh 21

Review of Progress Summary of major decision points »Research data use scenarios, thematic areas, and use cases Materials will be posted on Confluence »You will receive links to relevant documents via »We will revise and post the updated versions for our next meeting Last meeting: Wednesday, April 27, 2016 at 1:00pm (ET) 22

Confluence Please access the Confluence site for this initiative using this link: » Research+Scenario+Initiative+and+Legal+Analysis+and+Ethics+Framework+Dev elopment+Homehttp://confluence.siframework.org/display/PSRSI/PCOR+Privacy+and+Security+ Research+Scenario+Initiative+and+Legal+Analysis+and+Ethics+Framework+Dev elopment+Home All notes and slides from previous meetings are available: » If you are interested in the Patient Choice project, you can access their project page via Confluence: » 23

Meeting Schedule Meetings will be held biweekly from 1-2pm ET on the following dates: 24 Meeting 1 (kickoff)Tuesday, December 1, 2015 Meeting 2Wednesday, December 16, 2015 Meeting 3Wednesday, January 6, 2016 Meeting 4Wednesday, January 20, 2016 Meeting 5Wednesday, February 3, 2016 Meeting 6Wednesday, February 17, 2016 Meeting 7Wednesday, March 2, 2016 Meeting 8Wednesday, March 16, 2016 Meeting 9Wednesday, March 30, 2016 Meeting 10Wednesday, April 6, 2016 Meeting 11Wednesday, April 20, 2016 Meeting 12Wednesday, April 27, 2016

Thank You